Phase 1-2a dose-ranging study of TLK286 [canfosfamide] in combination with paraplatin (carboplatin) in recurrent ovarian cancer.
Phase of Trial: Phase I/II
Latest Information Update: 22 Jul 2011
At a glance
- Drugs Canfosfamide; Carboplatin
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2011 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 30 Sep 2005 New trial record.